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Differential effects of 
Cytomegalovirus carriage on the 
immune phenotype of middle-aged 
males and females
Marieke van der Heiden1,2, Menno C. van Zelm3,4, Sophinus J. W. Bartol3, Lia G. H. de Rond1, 
Guy A. M. Berbers1, Annemieke M. H. Boots2 & Anne-Marie Buisman1
The elderly population is more susceptible to infections as a result of an altered immune response, 
commonly referred to as immunosenescence. Cytomegalovirus (CMV)-infection associated changes in 
blood lymphocytes are known to impact this process, but the interaction with gender remains unclear. 
Therefore, we analysed the effects and interaction of gender and CMV on the absolute numbers of a 
comprehensive set of naive and memory T- and B-cell subsets in people between 50 and 65 years of age. 
Enumeration and characterisation of lymphocyte subsets by flow cytometry was performed on fresh 
whole blood samples from 255 middle-aged persons. CMV-IgG serostatus was determined by ELISA. 
Gender was a major factor affecting immune cell numbers. CMV infection was mainly associated with an 
expansion of late-differentiated T-cell subsets. CMV+ males carried lower numbers of total CD4+, CD4+ 
central memory (CM) and follicular helper T-cells than females and CMV− males. Moreover, CMV+ 
males had significantly lower numbers of regulatory T (Treg)-cells and memory B-cells than CMV+ 
females. We here demonstrate an interaction between the effects of CMV infection and gender on T- and 
B-cells in middle-aged individuals. These differential effects on adaptive immunity between males and 
females may have implications for vaccination strategies at middle-age.
Evidence is accumulating that the increased morbidity, risk for infections, and reduced vaccination responses in 
elderly are associated with changes in immune function1–4. Several heritable and non-heritable factors, such as 
chronological age, cytomegalovirus (CMV) infection, and gender have been documented to affect this process5, 
which is termed immunosenescence1–4.
Chronological age is primarily associated with alterations in the adaptive part of the immune system, espe-
cially the T-cell compartment. With age, thymic output of naive T-cells decreases to less than 10% of the original 
function by the age of 50 years6,7. This leads to increased peripheral replication of T-cells7,8, a reduction in naive 
T-cell numbers, and an expansion of memory T-cells9–13. Combined, these changes result in a diminished diver-
sity of the T-cell receptor (TCR) repertoire, which may negatively impact on the recognition of novel antigens 
with age14. In addition, the numbers of several other lymphocytes are affected by age. Multiple studies have shown 
higher numbers of regulatory T-(Treg) cells15–17 and CD4+ CD45RA+ CD25dim naive T-cells8,18 in elderly than in 
young adults. Moreover, an inverted CD4/CD8 T-cell ratio is observed with age, and has been proposed to be an 
immune risk indicator19,20. Finally, multiple studies showed an age-associated decline in the numbers of B-cells, 
both of the naive and the memory subsets2,3,21,22.
Multiple intrinsic and extrinsic factors may affect the immune status and infection with cytomegalovirus 
(CMV) has been associated with enhanced immunosenescence23–25. This herpes virus remains persistent upon 
primary infection and is actively suppressed by the immune system23. CMV infection primarily results in accu-
mulation of late-differentiated memory T-cells, both in the CD4 and CD8 T-cell lineage24–26. These effects are 
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already apparent in CMV-infected children27. CMV has limited effects on B-cell numbers, but might affect B-cell 
function as it is associated with high mutation frequencies in IgM and IgG transcripts28.
Gender is a major intrinsic factor that affects circulating immune cell numbers and immune function17,19,29,30. 
These effects can be mediated by hormone levels30–33, as well as by genes on sex chromosomes33. However, the 
impact of gender on naive and memory T- and B-cell numbers remains incompletely understood29. Recent stud-
ies suggest that T-cell senescence might be more pronounced in elderly men than in women17,29. Furthermore, the 
impact of persistent viruses, including CMV, might differ between males and females.
For a better understanding of immunosenescence, it is necessary to dissect the individual and combined 
effects of age, CMV infection and gender on numbers of circulating T- and B-cell subsets. Insights into these 
effects can be directly translated into early markers for immunosenescence. This knowledge is important in view 
of the general ageing of the population, because vaccines might be more effective when given before the onset of 
immunosenescence rather than at a specific age34,35.
In an effort to understand the effects and interaction of gender and CMV on the immune phenotype in a 
Dutch middle-aged population (defined as 50–65 years of age), we have enumerated a comprehensive set of 
T- and B-cell subsets including Treg cells, follicular helper T- (TFH) cells, and the ageing-associated CD4+ 
CD45RA+ CD25dim naive T-cells. The characterisation of these ‘immune markers’ may help the identification of 
persons being at risk of impaired immune function and thereby higher susceptibility to disease. Our data reveal 
that CMV infection differentially affects the immune phenotype in middle-aged males and females.
Results
Characteristics of study participants. A total of 255 persons participated in the study with mean age: 
57.7 (50–65) years, and of which 140 were male (54.9%). About half of the participants were seropositive for 
CMV. Baseline characteristics are shown in Table 1. Five participants were excluded from the analysis due to 
CMV status ambiguity. Mean age and BMI were similar between males and females, as well as between CMV+ 
and CMV− individuals.
Effects of CMV on the absolute numbers of circulating leukocyte subsets. CMV infection sig-
nificantly influenced 8 out of the 28 (28.5%) leukocyte subsets depicted in Table 1. A significantly lower number 
of NK-cells (p = 0.046) was observed in CMV+ persons (Table 1). In both the CD8 and CD4 T-cell lineage, 
the absolute numbers of late-differentiated effector memory (EM) TemRO and TemRA cells were significantly 
increased (all p < 0.0001) in CMV+ individuals (Fig. 1b,d). This resulted in significantly higher numbers of total 
CD8 T-cells (p = 0.036) in CMV+ individuals. The numbers of total CD4 T-cells were not different, because 
higher numbers of late-differentiated memory cells were accompanied by significantly lower numbers of naive 
(p = 0.023) and central memory (p = 0.030) CD4 T-cells (Table 1 and Fig. 1d). No differences were observed for 
TFH and Treg cell numbers. Finally, as a consequence of the above-mentioned changes, the CD4/CD8 ratio was 
significantly lower in CMV+ individuals (p < 0.0001, Table 1).
Effects of gender on the absolute numbers of circulating leukocyte subsets. Gender was asso-
ciated with significant differences in 17 out of the 28 (60.7%) leukocyte subsets (Table 1). First, males showed 
significantly (p < 0.0001) lower numbers of total lymphocytes, resulting from low numbers in multiple subsets, 
especially the T-cells (p < 0.0001). As both numbers of CD4 T-cells (p < 0.0001) and CD8 T-cells (p = 0.006) 
were affected, no difference was observed in the CD4/CD8 ratios between males and females. In addition, males 
showed lower numbers of naive cells within both these lineages (both p < 0.0001). Except for the memory Treg 
cells, gender was associated with significant changes in the absolute numbers of all measured CD4 T-cell subsets, 
including the CD45RA+ CD25dim cells (p = 0.0008). Finally, males carried lower numbers of B-cells (p = 0.019) 
than females, which was mostly due to lower numbers of memory B-cells (CD27− , p = 0.007; CD27+ , p = 0.004).
Combined effects of CMV and gender on the absolute numbers of major lymphocytes sub-
sets. To determine whether CMV infection was associated with differential effects on the immune pheno-
type between males and females, the participants were divided into four different groups: CMV− males, CMV+ 
males, CMV− females, and CMV+ females (Table 2). Mean age (57.7 years) and BMI (mean 25.9 range 18–39) 
were similar between the four study groups. Data on general health, lifestyle and biochemical parameters are 
reported in Supplementary Table 1. Furthermore, CMV infected males and females showed equal levels of 
CMV-specific IgG (Supplementary Fig.1).
Although CMV− males and females had similar total lymphocyte numbers in blood, these were significantly 
lower in CMV+ males than in CMV+ females (p < 0.0001; Table 2). This difference was mostly due to signifi-
cantly lower numbers of CD4 T-cells in CMV+ males than in CMV+ females (p < 0.0001) and in CMV− males 
(p = 0.037) and to a lesser extent due to lower B-cell numbers compared to CMV+ females (p = 0.029). As a 
consequence, CMV+ males showed a significantly lower CD4/CD8 ratio than CMV− males (p < 0.0001) and 
CMV+ females (p = 0.011). Moreover, only within the CMV+ males, 5/61 participants had a CD4/CD8 ratio 
below 1, which has been referred to as an immune risk profile19,20. The lower numbers of B-cells in CMV+ males 
were mainly due to lower numbers of CD27− (p = 0.028) and CD27+ (p = 0.0066) memory B-cells (Table 2 and 
Supplementary Fig. 2).
Combined effects of CMV and gender on the composition of the CD8 T-cell lineage. Besides rel-
atively stable absolute numbers of total CD8 T-cells, the composition of the CD8 T-cell lineage was affected by the 
combination of CMV and gender (Fig. 2a). Naive CD8 T-cell numbers were lower in males than in females, both 
in CMV+ (p = 0.0008) and CMV− (p = 0.0001) individuals (Fig. 2b). Moreover, the numbers of CD8 CM T-cells 
were significantly lower in CMV+ males than in CMV− males (p = 0.002) and in CMV+ females (p = 0.010) 
(Fig. 2c). Slightly different conclusions might be drawn when reporting on proportional data (Supplementary 
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Fig. 3b). The higher numbers of late-differentiated CD8 TemRA cells in CMV infected individuals was equal in 
males and females (Fig. 2e). Furthermore, the distributions of CD8 TemRA early, intermediate, and late cells were 
similar between CMV-infected males and females (Fig. 2d).
Combined effects of CMV and gender on the composition of the CD4 T-cell lineage. CMV+ 
males carried lower numbers of CD4 T-cells, as a result of lower numbers of all CD4 subsets. Similar to naive 
CD8 T-cells, naive CD4 T-cell numbers were lower in males than in females, both in CMV+ (p = 0.005) and 
in CMV− (p = 0.007) donors (Fig. 3b). In addition, CD4 CM T-cells were lower in CMV+ males than in 
CMV− males (p = 0.0002) and in CMV+ females (p = 0.0002; Fig. 3c). However, different results were observed 
when considering proportional data on CD4 T-cell subsets due to the differences in total numbers of CD4 cells 
(Supplementary Fig. 3a). Numbers of total CD4 TemRA cells, however, were higher in females, independent of 
CMV infection. CMV+ males and females showed differences in the composition of CD4 TemRA cells, shift-
ing from early to intermediate and late-stage cells within the CD4 TemRA compartment (Fig. 3d). The number 
of late-differentiated CD4 TemRA cells was equal in males and females (Fig. 3e). The overall finding of lower 
numbers of CD4 T-cell subsets in CMV+ males compared to CMV+ females was also visible for the TFH-cells 
(p = 0.005; Fig. 3f).
Combined effect of CMV and gender on the absolute numbers of CD4+CD45RA+CD25dim and 
Treg cells. We next analysed the impact of CMV and gender on circulating total, naive and memory Treg 
subsets (Fig. 4a). Furthermore, we enumerated the peripherally expanded CD45RA+ CD25dim naive T-cell subset 
(population II; Fig. 4a) which accumulates with age18. In line with the lower numbers of other CD4 T-cells in 
CMV− CMV+ Male Female
Demographic factors
No. (%) 127 (50.8) 123 (49.2) 140 (54.9) 115 (45.1)
Mean age in years (range) 57.6 (50–65) 57.8 (50–65) 57.8 (50–65) 57.5 (50–65)
Mean BMI (range) 25.7 (19–39) 26.0 (18–36) 25.8 (19–35) 25.9 (18–39)
Leukocyte subsets (cells/μ l blood)
Granulocytes 2275 [2075–2495] 2198 [2018–2394] 2249 [2060–2457] 2240 [2041–2459]
Monocytes 198.5 [182.6–215.8] 182.5 [168.8–197.3] 192.8 [178.0–208.8] 188.5 [173.0–205.5]
NK cells 143.5 [126.0–163.3] 118.2 [103.0–135.6]* 131.6 [115.7–149.8] 131.3 [114.3–150.9]
Lymphocytes 2179 [2039–2329] 2174 [2030–2328] 1937 [1799–2087] 2367 [2204–2541]****
T cells 1548 [1428–1678] 1428 [1293–1577] 1317 [1201–1445] 1732 [1599–1875]****
 γ δ T cells 18.7 [16.01–21.85] 17.4 [14.95–20.17] 16.2 [14.0–18.8] 20.6 [17.6–24.1]*
 CD4/CD8 ratio 3.3 [3.0–3.6] 2.5 [2.3–2.7]**** 2.7 [2.5–2.9] 3.1 [2.8–3.3]
 CD8 T cells 331.7 [299.2–367.8] 368.0 [328.4–412.3]* 317.8 [285.0–354.3] 393.8 [354.9–437.0]*
  CD8 naive 74.0 [63.3–86.4] 64.7 [53.4–78.4] 51.3 [43.2–61.0] 100.9 [87.2–116.8]****
  CD8 CM 13.8 [11.7–16.2] 10.0 [8.5–11.7]* 11.1 [9.3–13.1] 13.0 [11.2–15.1]
  CD8 TemRO 142.4 [126.8–160.0] 151.3 [134.7–169.9] 144.6 [128.7–162.5] 151.9 [135.5–170.2]
  CD8 TemRA 63.2 [54.9–72.9] 102.3 [87.8–119.2]**** 72.3 [62.5–83.7] 88.9 [75.9–104.0]
 CD4 T cells 1084 [994.5–1181] 911.3 [817.0–1016] 852.0 [769.4–943.3] 1205 [1109–1309]****
  CD4 naive 414.0 [363.6–471.4] 310.3 [265.5–362.7]* 290.6 [251.1–336.3] 460.2 [405.3–522.5]****
  CD4 CM 262.1 [234.8–292.6] 206.7 [182.9–233.5]* 213.8 [188.4–242.7] 260.5 [235.3–288.4]*
  CD4 TemRO 202.2 [184.0–222.2] 206.3 [182.7–232.8] 181.2 [162.9–201.5] 239.5 [216.4–265.1]***
  CD4 TemRA 38.1 [32.8–44.3] 44.5 [37.8–52.3] 32.2 [28.0–37.0] 53.9 [45.9–63.3]****
  TFH cells 214.3 [189.4–242.5] 205.3 [178.9–235.6] 186.4 [162.7–213.5] 241.7 [215.9–270.6]*
  Treg cells 107.3 [97.5–118.1] 90.7 [80.4–102.4] 89.0 [79.7–99.4] 113.6 [102.4–126.0]***
   naive Treg 12.6 [10.7–14.7] 11.08 [9.5–13.0] 9.9 [8.4–11.5] 14.7 [12.7–17.0]***
   memory Treg 4.7 [4.0–5.6] 3.2 [2.7–3.8]** 3.9 [3.2–4.7] 4.0 [3.4–4.7]
   CD4+ CD45RA+ CD25dim 27.0 [23.1–31.5] 21.7 [18.3–25.6] 20.3 [17.3–23.9] 29.7 [25.5–34.4]***
B cells 286.7 [257.8–318.9] 265.8 [241.0–293.0] 259.2 [234.4–286.5] 301.8 [271.8–335.0]*
 transitional 9.5 [8.1–11.2] 7.7 [6.5–9.1] 7.9 [6.8–9.1] 9.7 [8.1–11.5]
 naive mature 175.3 [154.2–199.2] 162.2 [142.1–185.1] 160.9 [144.2–179.4] 183.2 [161.6–207.7]
 natural effector 22.1 [18.4–26.6] 26.6 [22.3–31.8] 21.7 [18.7–25.2] 23.8 [20.0–28.5]
 CD27− memory 15.5 [13.1–18.3] 15.3 [13.4–17.6] 14.8 [12.8–17.0] 19.2 [16.8–22.0]**
 CD27+ memory 32.8 [28.1–38.3] 36.6 [32.1–41.8] 29.0 [25.5–33.0] 36.7 [32.0–42.1]**
Table 1.  Individual effects of CMV and gender on the absolute numbers of different leukocyte subsets. 
Geometric mean of cells/μ l blood [95% CI]. CMV− and CMV+ persons were compared, as well as males and 
females. * p < 0.05, * * p < 0.01, * * * p < 0.001, * * * * p < 0.0001. Bold numbers indicate significant differences 
within one subset. After a multiple testing correction only values with p < 0.0014 are considered significant. 
Significant differences after correction for multiple testing are underlined.
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CMV+ males, Treg cell (population V; Fig. 4a) numbers were also lower in CMV+ males than in CMV+ females 
(p = 0.004; Fig. 4c). Similar to CD4 and CD8 naive cells, naive Treg cells (population III; Fig. 4a) were lower in 
males than in females, both in CMV+ (p = 0.021) and in CMV− (p = 0.019) donors (Fig. 4d). No gender effect 
was seen for memory Tregs (population IV; Fig. 4a). Interestingly, CMV infection was only associated with signif-
icantly lower numbers of memory Treg cells in males (p = 0.038), and not in females (Fig. 4e). Numbers of CD4+ 
CD45RA+ CD25dim cells were lower only in CMV+ males compared to CMV+ females (p = 0.016) (Fig. 4b).
The interaction between gender and CMV status on the absolute numbers of lymphocytes. 
The results mentioned above on CD4 T-cells, CM T-cells, TFH, and Treg cells indicate a possible interaction 
between CMV infection and gender. To test this interaction a linear regression was performed that included 
the interaction CMV* Gender (Table 3 and Supplementary Table 2). This analysis confirmed the previously 
observed effects of either gender or CMV on lymphocyte numbers. Moreover, the numbers of CD4 T-cells were 
Figure 1. Effect of CMV on the CD8 and CD4 T-cell lineages. (a) Gating strategies for the CD8 T-cell subsets. 
A representative example is shown. (b) A cumulative schematic overview of the geometric mean values of 
absolute numbers of CD8 naive, CM, TemRO, and TemRA cells in CMV− and CMV+ participants. TemRO 
and TemRA cells are split into early, intermediate, and late differentiation subsets. (c) Gating strategies for the 
CD4 T-cell subsets. A representative example is shown. (d) A cumulative schematic overview of the geometric 
mean values of absolute numbers of CD4 naive, CM, TemRO, and TemRA cells in CMV− and CMV+ 
participants. TemRO and TemRA cells are were split into early, intermediate, and late differentiated subsets. The 
Mann Whitney U test was used for statistical analysis. * p < 0.05, * * p < 0.01, * * * * p < 0.0001 (n = 250).
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significantly affected by the combination of gender and CMV, with only CMV+ males showing lower CD4 T-cell 
numbers. The absolute numbers of both CD4 and CD8 CM, and TFH cells were affected by CMV serostatus only 
in males. This analysis also revealed that in this cohort of middle-aged individuals, age affected the numbers of 
CD8 naive T-cells. Thus, in addition to CMV serostatus and age, the male gender is associated with phenotypic 
changes in lymphocytes, especially in combination with the persistence of CMV infection.
Discussion
In this study, we show that both gender and CMV infection influence the immune phenotype of middle-aged 
persons (n = 255), an important population for possible future disease-preventing interventions. CMV infection 
was mainly associated with an accumulation of late-differentiated T-cells in both the CD4 and CD8 T-cell lineage. 
Gender was a major factor influencing the immune phenotype in middle-aged persons, with male participants 
demonstrating lower absolute numbers of lymphocytes within the majority of subsets. On top of the gender dif-
ferences in naive T-cells, CMV+ males carried significantly lower numbers of CM CD4 and CD8 T-cells, as well 
as lower TFH, Treg and memory B-cells.
We show that middle-aged males have lower numbers of naive cells, both within the CD4 and CD8 T-cell lin-
eage, which is in agreement with the previously reported accelerated drop in numbers of lymphocytes, especially 
naive cells, during ageing in males17. In addition, we found lower numbers of CD4+ CD45RA+ CD25dim T-cells in 
the male participants. Recently, it was demonstrated that these CD4+ CD45RA+ CD25dim T-cells accumulate with 
age in healthy individuals via peripheral expansion mechanisms and thereby represent a broad and functional 
reservoir of naive T-cells8,18. Several studies report a positive correlation between the number of naive T-cells and 
vaccine responses36,37, most likely due to a higher TCR diversity12,14. Since males show lower numbers of naive 
T-cells, this might point towards a lower capacity to respond to new antigenic challenges, a component of the 
immunosenescence process.
The association between CMV seropositivity and the accumulation of late-differentiated memory subsets in 
both the CD4 and CD8 T-cell lineage is in line with the current consensus in literature24,26,27,29. We demonstrate 
that the accumulation of these cells in CMV infected individuals was similar in males and females, which is in 
agreement with the study by Di Benedetto et al.29.
We found that CD4 T-cell numbers were reduced only in CMV+ males. Although this effect has been 
observed before in CMV+ individuals26, we are the first to demonstrate that this did not occur in females of 
middle-age. Consequently, CMV+ males show a lower CD4/CD8 ratio, which was even below 1 in some par-
ticipants, indicative of an immune risk profile19. Importantly, when analysing proportional data, we and others29 
found higher frequencies of CD8 T-cells within the T-cell compartment in CMV+ males (Supplementary Fig. 3). 
This has frequently been interpreted as an increase in CD8 T-cells rather than a decline in CD4 T-cells29. Here, we 
clearly show that CMV+ males have lower numbers of CD4 T-cells. Therefore, proportional data alone, without 
enumeration of cells, should be interpreted with caution.
Male CMV− Male CMV+ Female CMV− Female CMV+
Demographic factors
No. (%) 76 (30) 61 (24) 51 (20) 62 (25)
Mean age (range) 57.9 (50–65) 57.9 (50–65) 57.2 (50–65) 57.8 (50–65)
Mean BMI (range) 25.8 (19–39) 26.1 (18–36) 25.7 (19–35) 25.9 (19–35)
Leukocyte subsets (cells/μ l blood)
Lymphocytes 2043 [1854–2251] 1820 [1624–2041]****a 2367 [2078–2696] 2405 [2223–2602]
NK cells 145.9 [122.8–173.5] 110.1 [90.7–133.6] 139.8 [114.2–171.2] 126.7 [103.9–154.5]
Monocytes 202.1 [182.0–224.4] 177.8 [158.6–199.3] 193.0 [167.5–222.5] 187.2 [167.9–208.8]
Granulocytes 2392 [2140–2675] 2059 [1810–2342] 2105 [1792–2473] 2344 [2092–2625]
T cells 1422 [1292–1567]*b 1164 [991.8–1367]**** a 1756 [1532–2012] 1746 [1583–1927]
 CD4 T-cells 989.4 [891.0–1099]*b 701.1 [589.4–833.8]****a/*c 1242 [1076–1432] 1180 [1065–1306]
 CD8 T-cells 304.7 [267.3–347.3] 329.0 [274.8–394.0] 376.5 [318.8–444.7] 410.9 [357.4–472.3]
 CD4/CD8 ratio 3.2 [2.9–3.6] 2.1 [1.9–2.4]*a/****c 3.3 [2.9–3.8] 2.9 [2.5–3.2]
 Treg cells 100.8 [89.5–113.6] 74.7 [62.0–90.0]**a 117.8 [100.2–138.5] 109.8 [95.2–126.8]
 γ δ T-cells 16.3 [13.4–19.8] 16.3 [13.0–20.4] 22.9 [17.8–29.5] 18.5 [15.1–22.7]
B cells 273.9 [237.3–316.1] 235.9 [207.2–268.6]*a 306.9 [261.2–360.6] 298.8 [259.0–344.7]
 transitional 8.2 [6.6–10.1] 7.1 [5.7–8.8] 12.0 [9.3–15.3] 8.4 [6.5–10.7]
 naive mature 167.8 [143.4–196.4] 149.1 [129.1–172.3] 194.3 [162.5–232.3] 174.0 [145.4–208.1]
 natural effector 21.6 [18.0–26.0] 20.0 [15.6–25.8] 20.9 [15.7–27.9] 27.3 [21.9–34.1]
 CD27− memory 15.7 [12.6–19.5] 13.3 [11.3–15.6]*a 19.7 [15.8–24.5] 19.2 [16.2–22.7]
 CD27+ memory 29.7 [24.8–35.5] 27.4 [22.9–32.9]**a 33.3 [26.2–42.2] 41.5 [35.6–48.3]
Table 2.  Combined effects of CMV and gender on the absolute numbers of different leukocyte subsets. 
Geometic mean of cells/μ l blood [95% CI]. * p < 0.05, * * p < 0.01, * * * p < 0.001, * * * * p < 0.0001; a. Male CMV+ 
versus Female CMV+ ; b. Male CMV− versus Female CMV− ; c. Male CMV+ versus Male CMV− ; Bold 
numbers indicate significant differences within one subset. After a multiple testing correction only values with 
p < 0.0014 are considered significant. Significant differences after correction for multiple testing are underlined.
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The reduction in CD4 and CD8 CM T-cells in CMV+ males could be the result of less generation from their 
precursors, as these naive cells were reduced as well. Alternatively, it might indicate a higher turnover of CM 
T-cells towards more exhausted effector memory cell types in these males and thereby inducing a decrease in the 
capacity of developing memory immunity towards other pathogens. The latter explanation is in line with previous 
literature38 and the growing evidence of a higher susceptibility towards infections in older males32,39. However, 
our results are in contrast to results by Di Benedetto et al., who did not find an effect of CMV on the relative 
proportions of CM cells in elderly29. This difference could be explained by the small sample size or the older age 
group as compared to our cohort.
In addition to lower numbers of naive and CM T-cells, CMV+ males also carried lower numbers of TFH cells 
and memory B-cells. TFH cells provide co-stimulation for activated B-cells in the germinal centre and thereby 
stimulate memory B-cell responses40. Moreover, TFH cell numbers are associated with functional immunity and 
are reported to decrease with age41,42. Consequently, the parallel decrease in numbers of TFH and memory B-cells 
is indicative for a reduced capacity of humoral immune responses in CMV+ males.
Although CMV+ males show multiple differences in immune cell numbers of which some might be indic-
ative for accelerated immune ageing, males do not show higher numbers of (memory) Treg cells. This suggests 
that the pro- and anti-inflammatory balance in the immune system is still intact in these males. Previously, it has 
been shown in elderly that the balance between regulatory and effector CD4 T-cells is shifted towards a more 
suppressive, anti-inflammatory phenotype which is caused mainly by increases in memory Treg cells43. We have 
not observed this yet in the middle-aged group in our study. Furthermore, we found that the lower numbers of 
naive T-cells in males were accompanied by lower numbers of naive Treg cells. This aspect is in accordance with 
reports showing that naive Treg cells decrease with age43 and fits with the general decrease in naive cells with 
advancing age.
Despite the clear effects of gender and CMV infection on the immune phenotype in middle-aged persons, the 
variability in cell numbers between individuals was high. This variability indicates that most likely other heritable 
or non-heritable factors influence leukocyte numbers. Environmental factors, including infections with other 
persistent viruses, may have an impact on the blood lymphocyte numbers27. However, the current cohort was not 
found suitable for the analysis of many of these effects, because 92.6% of the participants were seropositive for 
EBV and the same applies for varicella zoster virus44,45. In addition, health status, BMI, smoking, and other life-
style factors could have affected the numbers of cells in the various leukocyte subsets46–49. However, in our cohort, 
the general health status, smoking, and physical activity habits were similar between the four different groups 
(Supplementary Table 1). Therefore, it is unlikely that these factors have impacted on our results. Moreover, 
besides a high variation between individuals in BMI values, we did not observe any effects of BMI on the numbers 
of cells in the lymphocyte subsets (data not shown). This could be related to the specific age group that we studied. 
Figure 2. The combined effects of gender and CMV on the absolute numbers of CD8 T-cell subsets. (a) A 
cumulative schematic overview of the geometric mean values of absolute numbers of CD8 naive, CM, TemRO, 
and TemRA cells in CMV+ and CMV− males and females. (b) Absolute numbers of CD8 naive T-cells in 
CMV+ and CMV− males and females. (c) Absolute numbers of CD8 CM T-cells in CMV+ and CMV− males 
and females. (d) A cumulative schematic overview of the geometric mean values of absolute numbers of early, 
intermediate, and late differentiated subsets within the CD8 TemRA cells in CMV+ and CMV− males and 
females. The number of total CD8 TemRA cells was compared between the groups. (e) Absolute numbers 
of CD8 TemRA late cells in CMV+ and CMV− males and females. The Geometric mean is indicated in the 
graphs, and the Kruskal-Wallis test was used for statistical analysis. * p < 0.05, * * p < 0.01, * * * p < 0.001,  
* * * * p < 0.0001 after Bonferroni correction (n = 250).
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Figure 3. The combined effects of gender and CMV on the absolute numbers of CD4 T-cell subsets. (a) A 
cumulative schematic overview of the geometric mean values of absolute numbers of CD4 naive, CM, TemRO, and 
TemRA cells in CMV+ and CMV− males and females. The number of total CD4 T-cells was compared between the 
groups. (b) Absolute numbers of CD4 naive T-cells in CMV+ and CMV− males and females. (c) Absolute numbers 
of CD4 CM T-cells in CMV+ and CMV− males and females. (d) A cumulative schematic overview of the geometric 
mean values of absolute numbers of early, intermediate, and late differentiated subsets within the CD4 TemRA cells 
in CMV+ and CMV− males and females. The number of total CD4 TemRA cells was compared between the groups. 
(e) Absolute numbers of CD4 TemRA late cells in CMV+ and CMV− males and females. (f) Absolute numbers of 
TFH cells in CMV+ and CMV− males and females. The Geometric mean is indicated in the graphs, and the Kruskal-
Wallis test was used for statistical analysis. *p < 0.05, * * p < 0.01, * * * p < 0.001, * * * * p < 0.0001 after Bonferroni 
correction (n = 250).
Figure 4. The combined effects of gender and CMV on the absolute numbers of CD4+CD45RA+CD25dim 
T-cells and Treg cells. (a) Gating strategies for the different cell subsets. A representative sample is shown. 
(b) Absolute numbers of CD45RA+ CD25dim T-cells in CMV+ and CMV− males and females. (c) Absolute 
numbers of Treg cells in CMV+ and CMV− males and females. (d) Absolute numbers of naive Treg cells in 
CMV+ and CMV− males and females. (e) Absolute numbers of memory Treg cells in CMV+ and CMV− 
males and females. The Geometric mean is indicated in the graphs, and the Kruskal-Wallis test was used for 
statistical analysis, * p < 0.05, * * p < 0.01, after Bonferroni correction (n = 250).
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Still, it should be noted that the self-reported weight and height introduced additional variation and that our 
study might not be fully powered to conclude on effects of BMI.
The effects of CMV infection in females were limited to the expansion of late-differentiated cell subsets, 
whereas CMV-infected males also showed lower numbers in CD4 T-cell subsets, as well as CD8 CM T-cells. These 
findings suggest that the female immune system might be better able to control CMV at middle-age. This effect 
is most likely mediated by differential effects of sex hormones on the immune response, since estradiol is found 
to mainly enhance immune responses, whereas testosterone mainly has a suppressive effect30,32. In this cohort, 
dehydroepiandrosterone sulphate (DHEAs) levels, the precursor for most major sex hormones50, were higher in 
males than in females (Supplementary Table 1). For both genders DHEAs levels showed a slight decrease between 
the age of 50 and 65 (data not shown). These findings are in agreement with existing knowledge51,52. Moreover, it 
is most likely that not all females in this cohort have been through the menopause, which might influence their 
estrogen levels33. Still, this will not have affected our results much, because the age distribution and DHEAs levels 
were similar between the CMV+ females and CMV− females. It is possible that CMV affects the immune pheno-
type more in elderly females, when the protective effect of estrogen subsides. The more extensive effect of CMV 
on the immune phenotype in middle-aged males might be mediated by high testosterone levels that suppress 
their immune response towards CMV reactivation. This outcome would be in line with the growing evidence of 
a higher susceptibility towards infections in males and the higher resistance to infectious diseases in females32. 
The latter could probably be related to better management of infection and preserved capacity to recognize novel 
pathogens in females of middle-age.
Our data reveal early signs of immunosenescence in middle aged, CMV+ males. Based on the accelerated 
immune ageing in males17 and an enlarged effect of CMV at elderly age26 as reported by others, we expect a pro-
gressive increase of immunosenescent features with ageing in CMV+ males. Differences between CMV+ and 
CMV− females may become more apparent beyond the age of 65. Follow-up studies are required to assess if these 
gender differences in more elderly study groups will remain to exist or even progress.
In conclusion, we found a direct association between gender, CMV and the immune phenotype of middle-aged 
individuals. The reductions in circulating CCR7+ naive and central memory T-cells as well as memory B-cells 
could have a direct impact on adaptive immune responses and are suggestive of early immunosenescence in 
CMV+ males, a notion that would merit further investigation. Since middle-aged individuals are an interesting 
population for future vaccine interventions, our findings are of direct relevance for future strategies regarding 
vaccination of the ageing population.
Methods
Study subjects and blood sampling. Peripheral blood was collected after written informed consent was 
obtained from 255 healthy middle-aged persons, aged 50–65 years of age, who were equally distributed over three 
5-year intervals: 50–54, 55–59, and 60–65 years. The study was approved by the Medical Ethical Committee: 
Verenigde Commissie Mensgeboden Onderzoek (VCMO) in Nieuwegein, the Netherlands and registered at the 
Dutch trial register (NTR4636). All procedures were in accordance with the Declaration of Helsinki.
Subjects were excluded if they had fever or used antibiotics within the last 14 days, had a serious immune 
related disease such as cancer, received immunosuppressive treatment within the last 3 months (e.g. steroids), had 
a known or suspected immune deficiency, a coagulation disorder or a neurologic disorder, used hormone treat-
ment, or were administered blood products within the last 6 months. All participants completed a short ques-
tionnaire concerning health status, medication use, smoking, and physical activity. Weight and height obtained 
from the short health questionnaire were used to calculate the Body Mass Index (BMI) according to the formula 
BMI = Weight (kg)/Height (m)2.
Blood samples were collected during evening hours in tubes containing lithium heparin (BD Biosciences, 
Franklin Lakes, New Jersey) for detailed cellular immune phenotyping within 24 hours after collection. 
Additionally, serum was collected using serum clotting tubes (BD Biosciences) and processed within 6 hours for 
storage at − 20 °C.
CMV and EBV serology. Serum CMV IgG was determined by an enzyme-linked immunoassay 
(ETI-CYTOK-G Plus, P002033, Diasorin, Salugga, Italy) according to the manufacturer’s indications. The thresh-
old for CMV seropositivity was 0.4 IU/ml. Serum Epstein Barr Virus (EBV)-capsid antigen IgG was determined 
by an enzyme-linked immunoassay (EUROIMMUN, Lubeck, Germany) according to the manufacturer’s indica-
tions. The threshold for EBV seropositivity was 20 relative units (RU)/ml.
Biochemical parameter measurements. Serum levels of C-reactive protein (CRP), Rheumatoid Factor 
(RF), and Reactive Oxygen Metabolites (ROM) were measured with a clinical auto-analyser (Dx5, Beckman-Coulter). 
The kits used were from Beckman-Coulter, Fullerton, CA (CRP), Roche Diagnostics, Almere, The Netherlands (RF), 
and Diacron, Grosseto, Italy (ROM). Dehydroepiandrosterone Sulphate (DHEAs), a precursor for most major sex 
hormones53, was measured using the kit and immuno-analyser Access-2 from Beckman Coulter.
Flow cytometric immune phenotyping. The absolute numbers of lymphocytes, CD3+ T-cells, 
B-cell subsets, NK-cells, monocytes, and granulocytes were determined with a lyse-no-wash protocol using 
TruCOUNT tubes (BD Biosciences, San Jose, CA, USA). The following fluorochrome-conjugated antibod-
ies were used: CD3(UCHT1)-BV711, CD16(B73.1)-PE, and CD38(HB7)-APC-H7 (all from BD Biosciences), 
CD45(GA90)-OC515 and CD56(C5.9)-PE (both from Cytognos, Salamanca, Spain), CD27(M-T271)-BV421 
and IgD(IA6-2)-FITC (both from Biolegend, San Diego, CA), and CD19(J3-119)-PE-Cy7 (Beckman Coulter, 
Fullerton, CA).
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Leukocyte subsets Predicting variable p-value β coefficient R2 model
Lymphocytes 
CMV status 0.869 0.015
0.072
Gender 0.046* −0.176
Gender* CMV 0.227 − 0.129
Age 0.375 0.055
T cell
CMV status 0.928 − 0.008
0.108
Gender 0.016* −0.209
Gender* CMV 0.124 − 0.162
Age 0.422 0.049
CD4 T cell
CMV status 0.580 − 0.049
0.153
Gender 0.015* −0.206
Gender*CMV 0.029* −0.223
Age 0.452 0.044
 CD4 naive 
CMV status 0.048* −0.178
0.121
Gender 0.002* −0.272
Gender* CMV 0.652 − 0.047
Age 0.547 0.036
 CD4 CM T cell
CMV status 0.820 0.021
0.102
Gender 0.801 0.022
Gender*CMV 0.001* −0.342
Age 0.855 0.011
 CD4 TemRO 
CMV status 0.135 0.138
0.074
Gender 0.237 − 0.104
Gender*CMV 0.032* −0.230
Age 0.801 0.016
 CD4 TemRO late 
CMV status 0.000* 0.585
0.305
Gender 0.612 0.039
Gender* CMV 0.586 − 0.050
Age 0.732 − 0.018
 CD4 TemRA
CMV status 0.444 0.070
0.083
Gender 0.003* −0.263
Gender* CMV 0.858 − 0.019
Age 0.555 0.036
 CD4 TemRA late
CMV status 0.000* 0.430
0.260
Gender 0.044* −0.161
Gender* CMV 0.403 0.080
Age 0.485 0.039
 TFH
CMV status 0.342 0.089
0.053
Gender 0.479 − 0.063
Gender*CMV 0.045* −0.217
Age 0.518 0.040
CD8 T-cell
CMV status 0.440 0.072
0.038
Gender 0.057 − 0.171
Gender* CMV 0.940 − 0.008
Age 0.766 − 0.019
 CD8 naive 
CMV status 0.310 − 0.089
0.169
Gender 0.000* −0.340
Gender* CMV 0.870 − 0.017
Age 0.001* −0.196
 CD8 CM T cell
CMV status 0.656 − 0.041
0.070
Gender 0.908 0.010
Gender*CMV 0.029* −0.235
Age 0.254 0.071
 CD8 TemRO
CMV status 0.110 0.152
0.015
Gender 0.545 0.055
Gender* CMV 0.114 − 0.175
Age 0.712 0.023
Continued
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Detailed immune phenotyping of T-cell subsets was performed separately in fresh whole blood samples using 
additional antibodies: CD4(RPA-T4)-BV510, CD45RA(HI100)-BV605 and CD28(CD28.2)-PerCP- Cy5.5 (all 
from Biolegend), CCR7(150503)-PE-CF594, CD8(SK1)-APC-H7, CD25(2A3)-FITC, and TCRgd(11F2)-PE-Cy7 
(all from BD Biosciences), and CXCR5(51505)-APC (R&D systems, Minneapolis, MN). Absolute numbers of 
T-cell subsets were calculated using the CD3+ T-cell numbers from the TruCOUNT analysis. Gating strategies 
for T-cells54, Treg cells55, and B-cells56 were applied as described previously, and shown in Figs 1a,c and 4a and 
Supplementary Fig. 2A, respectively. In short, CCR7+ T cells were separated into CD45RA+ naive and CD45RA- 
central memory (CM) subsets as described by Sallusto et al.57. Furthermore, CCR7- effector memory T cells 
(Tem) were separated into CD45RA- TemRO and CD45RA+ TemRA cells. Within TemRO and TemRA, early, 
intermediate and late subsets were defined on the basis of differential expression of CD27 and CD28, as described 
by Appay et al.58. In previous studies, CD45RA- T cells were confirmed to be CD45RO+ 27. Flow cytometric 
analyses were performed on a 4-laser LSRFortessa (BD Biosciences) using standardized measurement settings 
as described by Kalina T et al.59, and data analysis using FacsDiva V8 (BD Biosciences) and FlowJo V10 (FlowJo 
company, Ashland, OR).
Statistics. Normal distribution of the data was tested with the D’Agostino & Pearson omnibus normality test.
The Mann Whitney U test was used to compare the CMV+ and CMV− groups, and males versus females 
on single immune cell subsets. To determine significant differences of one cell subset between two groups, 
p-values < 0.05 were considered significant. CMV+ males, CMV− males, CMV+ females, and CMV− females 
were compared for every immune cell subset using the Kruskal-Wallis test adjusted for multiple comparisons 
with the Bonferroni correction. The following comparisons were made: CMV+ males vs CMV+ females, CMV+ 
males vs CMV− males, CMV+ females vs CMV− females, CMV− females vs CMV− males. These statistical 
tests were performed in GraphPad Prism v6.05 for Windows (GraphPad Software Inc., La Jolla, CA). To conclude 
whether gender, CMV or the interaction between gender and CMV had an effect on the immune phenotype, a 
multiple comparison correction was included, since 36 immune cell subsets were tested. Only p-values < 0.0014 
(p = 0.05/36) were considered significant. The statistical tests were supplemented with an Enter linear regression 
method in SPSS V22.0 to determine the individual effects of CMV status, gender, age, and the interaction between 
CMV status and gender on the immune cell subsets. Non-normally distributed data were log-transformed. To 
confirm the differential effects of CMV in males and females, an interaction term, gender* CMV, was included in 
the analysis. In this model, the p-value indicates whether a variable was significantly associated with the absolute 
number of the respective immune cells. The β coefficient indicates the strength of the association; the higher the 
value of β , the larger the deviation between groups that were compared. A negative value indicates a lower number 
of cells within males, CMV+ individuals, or CMV+ males, whereas a positive value indicates a higher absolute 
number of cells in these groups. The R2 of the model explains the strength of the model in predicting the absolute 
number of the respective immune cells; the closer the R2 is to 1, the stronger the predictive value of the model.
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